PDCD1 and neoplasm: Previous work from our group led to the discovery that expansion of tumor-infiltrating T lymphocytes arises from novel rather than preexisting clones in a cohort of locally advanced and metastatic cutaneous carcinoma patients treated with PD-1 inhibitors (7).